Artwork

内容由Xtelligent Healthcare Media提供。所有播客内容(包括剧集、图形和播客描述)均由 Xtelligent Healthcare Media 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Exploring gaps in GLP-1 research, care, and coverage

16:35
 
分享
 

Manage episode 449532754 series 2797294
内容由Xtelligent Healthcare Media提供。所有播客内容(包括剧集、图形和播客描述)均由 Xtelligent Healthcare Media 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

GLP-1 drugs, like Ozempic, Wegovy, and Zepbound, have gained attention for their significant health impacts and anti-obesity effects. However, there continues to be a lot of unknowns surrounding these medications, their long-term impacts, and access.

Featuring: Dr. Lydia Alexander, an obesity medicine specialist, lifestyle specialist, president of the Obesity Medicine Association (OMA), Chief Medical Officer at Enara, and a medical chef.

In today’s episode, we’ll cover

  • The significant progress made in GLP-1 research, care delivery, and insurance coverage
  • Filling research gaps in GLP-1 care through longitudinal studies examining long-term medication effects and potential adverse reactions
  • Tips for providers managing patients on GLP-1 medications and patient-focused approaches to obesity management

And more!

To watch video clips from our podcast, subscribe to our YouTube channel, @Healthcare Strategies

Resources:

  continue reading

120集单集

Artwork
icon分享
 
Manage episode 449532754 series 2797294
内容由Xtelligent Healthcare Media提供。所有播客内容(包括剧集、图形和播客描述)均由 Xtelligent Healthcare Media 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

GLP-1 drugs, like Ozempic, Wegovy, and Zepbound, have gained attention for their significant health impacts and anti-obesity effects. However, there continues to be a lot of unknowns surrounding these medications, their long-term impacts, and access.

Featuring: Dr. Lydia Alexander, an obesity medicine specialist, lifestyle specialist, president of the Obesity Medicine Association (OMA), Chief Medical Officer at Enara, and a medical chef.

In today’s episode, we’ll cover

  • The significant progress made in GLP-1 research, care delivery, and insurance coverage
  • Filling research gaps in GLP-1 care through longitudinal studies examining long-term medication effects and potential adverse reactions
  • Tips for providers managing patients on GLP-1 medications and patient-focused approaches to obesity management

And more!

To watch video clips from our podcast, subscribe to our YouTube channel, @Healthcare Strategies

Resources:

  continue reading

120集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南